Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary W Price

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|January 12, 2002
Serotonergic targets in depressionDerek N Middlemiss, Gary W Price, Jeannette M Watson
Molecular Pharmacology|December 4, 2003
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modelingWarren D Hirst, Bjarke Abrahamsen, Frank E Blaney, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2005
Adverse reactions to ants other than imported fire antsJohn H Klotz, Richard D deShazo, Jacob L Pinnas, et al.
Biochemical Pharmacology|March 29, 2003
Pharmacological characterisation of a cell line expressing GABA B1b and GABA B2 receptor subunitsWarren D Hirst, Adam J Babbs, Andrew Green, et al.
Neuropharmacology|March 21, 2006
SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonistClaire Scott, Christopher J Langmead, Kirsten L Clarke, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2007
SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction testKathryn R Starr, Gary W Price, Jeannette M Watson, et al.
Neuropharmacology|April 4, 2006
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activityLee A Dawson, Zoë A Hughes, Kathryn R Starr, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Identification of a potent and selective 5-HT1B receptor antagonistPaul A Wyman, Howard R Marshall, Sean T Flynn, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
European Journal of Pharmacology|March 31, 2006
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissueClaire Scott, Ellen M Soffin, Matthew Hill, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|January 12, 2002
Serotonergic targets in depressionDerek N Middlemiss, Gary W Price, Jeannette M Watson
Molecular Pharmacology|December 4, 2003
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modelingWarren D Hirst, Bjarke Abrahamsen, Frank E Blaney, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2005
Adverse reactions to ants other than imported fire antsJohn H Klotz, Richard D deShazo, Jacob L Pinnas, et al.
Biochemical Pharmacology|March 29, 2003
Pharmacological characterisation of a cell line expressing GABA B1b and GABA B2 receptor subunitsWarren D Hirst, Adam J Babbs, Andrew Green, et al.
Neuropharmacology|March 21, 2006
SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonistClaire Scott, Christopher J Langmead, Kirsten L Clarke, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2007
SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction testKathryn R Starr, Gary W Price, Jeannette M Watson, et al.
Neuropharmacology|April 4, 2006
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activityLee A Dawson, Zoë A Hughes, Kathryn R Starr, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Identification of a potent and selective 5-HT1B receptor antagonistPaul A Wyman, Howard R Marshall, Sean T Flynn, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
European Journal of Pharmacology|March 31, 2006
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissueClaire Scott, Ellen M Soffin, Matthew Hill, et al.
Pageof 2